421-435 of 937
Health Information Technology's Impact on Adherence to Lipid Therapy
Lipid LuminationsHealth Information Technology's Impact on Adherence to Lipid Therapy
Cardiometabolic Consequences of Sitting Time
Lipid LuminationsCardiometabolic Consequences of Sitting Time
Generics and Manufacturing: What Prescribers Need to Know
Lipid LuminationsGenerics and Manufacturing: What Prescribers Need to Know
Genetic Testing for Familial Hypercholesterolemia
Lipid LuminationsGenetic Testing for Familial Hypercholesterolemia
Research Updates in Familial Hypercholesterolemia
Lipid LuminationsResearch Updates in Familial Hypercholesterolemia
Research Updates on Postprandial Dyslipidemia Treatment
Lipid LuminationsResearch Updates on Postprandial Dyslipidemia Treatment
- advertisement
Lipid Biomarker Updates: When to Move Beyond the Standard Profile
Lipid LuminationsLipid Biomarker Updates: When to Move Beyond the Standard Profile
What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patient
Lipid LuminationsWhat is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patient
Underrecognition of Diabetes in Cardiology Practice
Lipid LuminationsUnderrecognition of Diabetes in Cardiology Practice
An Avocado a Day: Does It Keep Heart Disease Away?
Lipid LuminationsAn Avocado a Day: Does It Keep Heart Disease Away?
The Impact of Inflammation on HDL Activity
Lipid LuminationsThe Impact of Inflammation on HDL Activity
- advertisement
Highlights From the Omnia/Prova Collaborative Educational Conference in New York
Conference CoverageHighlights From the Omnia/Prova Collaborative Educational Conference in New York
Advancements in Stroke Prevention: Anticoagulation for Nonvalvular Atrial Fibrillation, Part 3
Grand Rounds Nation®Advancements in Stroke Prevention: Anticoagulation for Nonvalvular Atrial Fibrillation, Part 3
Advancements in Stroke Prevention: Anticoagulation for Nonvalvular Atrial Fibrillation, Part 2
Grand Rounds Nation®Advancements in Stroke Prevention: Anticoagulation for Nonvalvular Atrial Fibrillation, Part 2



















